125 related articles for article (PubMed ID: 20478730)
1. Imatinib mesylate induces clinical remission in rheumatoid arthritis.
Pereira I; Fialho S; Castro G; Zimmermann A
Joint Bone Spine; 2010 Jul; 77(4):372-3. PubMed ID: 20478730
[No Abstract] [Full Text] [Related]
2. Maintained efficacy of the tyrosine kinase inhibitor imatinib mesylate in a patient with rheumatoid arthritis.
Eklund KK; Lindstedt K; Sandler C; Kovanen PT; Laasonen L; Juurikivi A; Wolff H; Mykkänen M; Joensuu H
J Clin Rheumatol; 2008 Oct; 14(5):294-6. PubMed ID: 18824923
[No Abstract] [Full Text] [Related]
3. Long-standing remission of Crohn's disease under imatinib therapy in a patient with Crohn's disease.
Magro F; Costa C
Inflamm Bowel Dis; 2006 Nov; 12(11):1087-9. PubMed ID: 17075351
[No Abstract] [Full Text] [Related]
4. Resolution of rheumatoid arthritis symptoms with imatinib mesylate.
Vernon MR; Pearson L; Atallah E
J Clin Rheumatol; 2009 Aug; 15(5):267. PubMed ID: 19654496
[No Abstract] [Full Text] [Related]
5. Long-term imatinib maintenance therapy for adult Philadelphia positive acute lymphoblastic leukemia.
Guillet S; Hirsch P; Marzac C; Mohty M; Marie JP; Legrand O
Leuk Lymphoma; 2014 Nov; 55(11):2646-8. PubMed ID: 24491028
[No Abstract] [Full Text] [Related]
6. Cessation of imatinib mesylate may lead to sustained hematologic and molecular remission in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome.
Helbig G; Kyrcz-Krzemień S
Am J Hematol; 2014 Jan; 89(1):115. PubMed ID: 24009127
[No Abstract] [Full Text] [Related]
7. Imatinib treatment of seropositive arthritis in a young woman with chronic myeloid leukemia.
Ames PR; Aye WW; Beatty C; O'Reilly D
J Rheumatol; 2008 Aug; 35(8):1682. PubMed ID: 18671330
[No Abstract] [Full Text] [Related]
8. Myelofibrosis with a novel translocation, t(1;3)(q31;q23), and response to imatinib mesylate.
Yalamanchili K; Liu D; Seiter K
Leukemia; 2007 Mar; 21(3):577-8. PubMed ID: 17230224
[No Abstract] [Full Text] [Related]
9. Is there a role for imatinib mesylate in the treatment of eosinophilic granulomatosis with polyangiitis?
Erre GL; Pardini S; Cuccuru L; Taras L; Passiu G
Joint Bone Spine; 2015 Jan; 82(1):72-3. PubMed ID: 25059880
[No Abstract] [Full Text] [Related]
10. Imatinib treatment of generalized localized scleroderma (morphea).
Moinzadeh P; Krieg T; Hunzelmann N
J Am Acad Dermatol; 2010 Nov; 63(5):e102-4. PubMed ID: 20950732
[No Abstract] [Full Text] [Related]
11. Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylate.
Silver RT
Curr Hematol Malig Rep; 2007 Feb; 2(1):43-6. PubMed ID: 20425387
[TBL] [Abstract][Full Text] [Related]
12. MDCT appearance of gastrointestinal stromal tumors after therapy with imatinib mesylate.
Warakaulle DR; Gleeson F
AJR Am J Roentgenol; 2006 Feb; 186(2):510-5. PubMed ID: 16423961
[TBL] [Abstract][Full Text] [Related]
13. The effect of homoharringtonine in patients with chronic myeloid leukemia who have failed or responded suboptimally to imatinib therapy.
Li YF; Liu X; Liu DS; Din BH; Zhu JB
Leuk Lymphoma; 2009 Nov; 50(11):1889-91. PubMed ID: 19860613
[No Abstract] [Full Text] [Related]
14. [Systemic mastocytosis without the typical mutation of codon 816 successfully treated with imatinib].
Hirayama Y; Konuma Y; Kohda K; Ando M; Obata M; Ueno Y; Sasagawa Y; Wada Y; Shirao S
Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2542-5. PubMed ID: 19051746
[No Abstract] [Full Text] [Related]
15. Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases.
Eklund KK; Joensuu H
Ann Med; 2003; 35(5):362-7. PubMed ID: 12952023
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for imatinib in inflammatory bowel disease?
De Backer O; Lefebvre RA
Inflamm Bowel Dis; 2008 Apr; 14(4):579-81. PubMed ID: 18050299
[No Abstract] [Full Text] [Related]
17. [Hypereosinophilic syndrome and Löffler endocarditis caused by FIP1L-PDGFRA rearrangement: effectiveness of imatinib mesylate therapy].
Mauri M; García M; Reynaga E; Ramila E
Med Clin (Barc); 2007 Jun; 129(4):159. PubMed ID: 17663975
[No Abstract] [Full Text] [Related]
18. Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis.
Haroche J; Amoura Z; Charlotte F; Salvatierra J; Wechsler B; Graux C; Brousse N; Piette JC
Blood; 2008 Jun; 111(11):5413-5. PubMed ID: 18502845
[No Abstract] [Full Text] [Related]
19. Imatinib for the treatment of rheumatic diseases.
Paniagua RT; Robinson WH
Nat Clin Pract Rheumatol; 2007 Apr; 3(4):190-1. PubMed ID: 17396105
[No Abstract] [Full Text] [Related]
20. Imatinib: as adjuvant therapy for gastrointestinal stromal tumor†: profile report.
Sanford M; Scott LJ
BioDrugs; 2011 Jun; 25(3):191-2. PubMed ID: 21627342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
